Néphroprotection. Comment ralentir l’évolution de l’insuffisance rénale chronique ?
Authors:
- Thierry KrummelTKThierry Krummel
- Laura Parvez-BraunLPLaura Parvez-Braun
- 1 May 2005
- journal article
- abstracts
- Published by JLE in Nephrologie & Therapeutique
- Vol. 1 (2) , 135-144
Abstract
Most nephropathies are characterized by a progression that may result in end-stage renal failure (ESRF). Apart from the specific treatment implemented when possible, ESRF may be delayed by nephroprotective therapy. Following the definition of the risk factors likely to induce progressive renal disease, the various therapeutic strategies that may play a nephroprotective role are reviewed. The potential results are described with regard to published data, in particular randomised trials, as recommended by the evidence-based medicine principles. Blockade of the renin-angiotensin system plays a major role in terms of nephroprotection. However, this strategy should not replace lifestyle measures and pharmacological treatment of the metabolic disorders associated to nephropathies.Keywords
This publication has 30 references indexed in Scilit:
- Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAALKidney International, 2004
- British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summaryBMJ, 2004
- Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)BMJ, 2004
- Practice Guidelines For Primary Care PhysiciansJournal Of Hypertension, 2003
- Retarding progression of chronic renal disease: The neglected issue of residual proteinuriaKidney International, 2003
- Proteinuria as a modifiable risk factor for the progression of non-diabetic renal diseaseKidney International, 2001
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001
- Low protein diets for chronic renal failure in non diabetic adults2000
- Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease studyAmerican Journal of Kidney Diseases, 1996
- Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal InsufficiencyNew England Journal of Medicine, 1996